NCT01020292 2019-04-12
A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
Abramson Cancer Center at Penn Medicine
Maastricht Radiation Oncology